|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
The 41st Annual Anatomic Pathology Conference was a huge success
The 2015 FSP Winter Meeting — 41st Annual Anatomic Pathology Conference — was held February 13-15, 2015 and was deemed a great opportunity for education, networking and the opportunity to meet the latest in products and services in the Exhibit Hall. Thanks to our residents – there were 40 Poster Presentations – all of high caliber. The vendors displayed the cutting edge tools and services for pathology laboratories, clinics and hospitals. Leica even displayed their mobile truck laboratory – very appreciated by all attendees.
Growing wave of hospital, health system mega-mergers means changing dynamics for pathology, clinical lab medicine
Large and financially-stable multi-hospital health systems are racing to form regional mega-systems. It's a strategy to get ahead of the Affordable Care Act's mandate to improve quality and increase efficiency through coordinated care across the entire care continuum. This growing national trend means further consolidation of clinical laboratory testing services within the merging organizations.
Gut microflora in cutting-edge allergy and asthma care
Technological advances are transforming how many physicians think about allergy and asthma. Delegates attending this year's American Academy of Allergy, Asthma & Immunology (AAAAI) conference will hear how the microbiome could change disease management. "They're now using DNA techniques, measuring certain types of RNA that only occur in bacterial or viral species," meeting program chair Paul Williams, M.D., told Medscape Medical News.
Lab-in-a-Box can aid doctor's bedside manner
R & D Magazine
They call it "the Lab-in-a-Box." According to Nadir Weibel, a research scientist in the Computer Science and Engineering department at UC San Diego, inside the box are assorted sensors and software designed to monitor a doctor's office, particularly during consultations with patients. The goal is to analyze the physician's behavior and better understand the dynamics of the interactions of the doctor with the electronic medical records and the patients in front of them. The eventual goal is to provide useful input on how to run the medical practice more efficiently.
Mutation detection in human in vitro fertilized embryos using whole-genome sequencing
Pre-implantation genetic diagnosis is used in fertility clinics to detect large chromosomal abnormalities or genetic mutations passed on by parents to their in vitro fertilized embryos. However, it is not possible to comprehensively scan the embryo's genome to detect spontaneous mutations. In a study published online in Genome Research, scientists developed a whole-genome sequencing approach using 5- to 10-cell biopsies from human embryos to detect potential disease-causing mutations.
Synthetic biology yields new approach to gene therapy
Bioengineers at The University of Texas at Dallas have created a novel gene-delivery system that shuttles a gene into a cell, but only for a temporary stay, providing a potential new gene-therapy strategy for treating disease. The approach offers distinct advantages over other types of gene therapies under investigation, said Richard Taplin Moore MS'11, a doctoral student in bioengineering in the Erik Jonsson School of Engineering and Computer Science.
Miss an issue of Pathology Today? Click here to visit the Pathology Today archive page.
UC San Diego, UC San Francisco launch new cancer cell mapping initiative
Researchers from the University of California, San Diego School of Medicine and University of California, San Francisco, with support from a diverse team of collaborators, have launched an ambitious new project — dubbed the Cancer Cell Map Initiative or CCMI — to determine how all of the components of a cancer cell interact.
New products, companies and innovation in healthcare
By Rosemary Sparacio
Theranos, Karyopharm Therapeutics, Organovo. These companies are at the forefront of leading-edge technology and new products in the healthcare industry. And the new advances in technology and manufacturing have made many of their products not only possible, but also viable and available. Lab data is usually the first and earliest way to figure out what is causing a disease and what clinical approach can be taken. Theranos has developed a new procedure to change the way in which diagnosis and therapy takes place.
Disclaimer: The authors, editors, and the Florida Society of Pathologists (FSP) Executive Committee affiliated with "Florida Pathology Today" e-Newsletter cannot and do not warrant the completeness, accuracy, non-infringement, merchantability, timeliness or fitness for a particular purpose of the information or views contained within this publication, or available through the links provided within articles contained within this publication.
FSP has no control over and does not officially endorse the content of the information available on the links contained in the "Florida Pathology Today" or links imbedded in articles within the "Florida Pathology Today." These links are provided as a courtesy only. Linked sites are not a part of the "Florida Pathology Today." The owners of those linked sites, and not FSP, own the intellectual property rights to the material on the linked sites. FSP cannot certify the accuracy of material published on linked sites. Additionally, the contents of this e-Newsletter and the above referenced links, including any advice, suggestions, and/or recommendations have NOT been generated as part of any professional evaluation.
The authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" e-Newsletter shall not be liable to anyone for any loss or injury caused in whole or in part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting or delivering this e-Newsletter and any information included in this e-Newsletter.
Under no circumstances will the authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" be liable to you or anyone else for any decision made or any action taken by you or anyone else in reliance on such information or view, or for any incidental, consequential, special, or similar damages even if advised of the possibility of such damages.
The above warranties are the only warranties of any kind either expressed or implied, including warranties of merchantability or fitness for any particular purpose.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063